Keyphrases
Plasminogen Activator inhibitor-1 (PAI-1)
100%
Spironolactone
100%
Mineralocorticoid Receptor
100%
Potassium-sparing Diuretics
100%
Triamterene
75%
Hypertensive Subjects
50%
Potassium
25%
Renin-angiotensin-aldosterone System
25%
Mineralocorticoid Receptor Antagonism
25%
Hydrochlorothiazide
25%
Hypertension
12%
Tissue Plasminogen Activator (t-PA)
12%
Blood Pressure
12%
Opposing Effects
12%
Treatment Group
12%
Drug Effects
12%
Regression Analysis
12%
Blood Serum
12%
Serum Potassium
12%
Aldosterone
12%
Molar Ratio
12%
Pharmacology, Toxicology and Pharmaceutical Science
Plasminogen Activator Inhibitor 1
100%
Fibrinolytic Agent
100%
Spironolactone
100%
Potassium Sparing Diuretic Agent
100%
Mineralocorticoid Receptor
100%
Triamterene
75%
Isotopes of Potassium
37%
Aldosterone
37%
Hydrochlorothiazide
25%
Renin
25%
Angiotensin
25%
Tissue Plasminogen Activator
12%
Treatment Group
12%